NWANNEDI IKE: Open Payments
NPI 1215631718 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 32 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,179
Food & beverage: $1,179
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $307 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $265 |
| AstraZeneca Pharmaceuticals LP | 5 | $194 |
| PFIZER INC. | 1 | $121 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| ABIOMED | 3 | $114 |
| Dexcom, Inc. | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Ozempic, Kerendia, AIRSUPRA, ABRYSVO, Auvelity, Dexcom G6 Transmitter, BREZTRI, HORIZANT.
Industry payments across TX — which companies pay providers there.
